Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$535K Buy
1,477
+202
+16% +$69.1K 0.03% 445
2026
Q1
$449K Sell
1,275
-99
-7% -$35.3K 0.03% 434
2025
Q4
$450K Sell
1,374
-7,306
-84% -$2.32M 0.03% 423
2025
Q3
$2.45M Buy
8,680
+325
+4% +$94.3K 0.11% 180
2025
Q2
$2.33M Buy
8,355
+1,349
+19% +$382K 0.11% 173
2025
Q1
$2.18M Buy
7,006
+819
+13% +$242K 0.12% 165
2024
Q4
$1.61M Buy
6,187
+136
+2% +$40.4K 0.1% 184
2024
Q3
$1.95M Buy
6,051
+71
+1% +$23.2K 0.12% 157
2024
Q2
$1.87M Buy
5,980
+171
+3% +$50.2K 0.13% 154
2024
Q1
$1.65M Buy
5,809
+209
+4% +$61.2K 0.12% 170
2023
Q4
$1.61M Buy
5,600
+55
+1% +$15K 0.13% 157
2023
Q3
$1.49M Buy
5,545
+52
+0.9% +$13K 0.14% 152
2023
Q2
$1.22M Sell
5,493
-466
-8% -$108K 0.12% 167
2023
Q1
$1.44M Buy
5,959
+378
+7% +$92.8K 0.15% 148
2022
Q4
$1.47M Sell
5,581
-6
-0.1% -$1.61K 0.17% 140
2022
Q3
$1.26M Buy
5,587
+52
+0.9% +$12.6K 0.15% 148
2022
Q2
$1.35M Buy
+5,535
New +$1.36M 0.17% 138
2021
Q3
Sell
-177
Closed -$43K 437
2021
Q2
$43K Buy
+177
New +$43.5K 0.01% 655
2021
Q1
Sell
-9,412
Closed -$2.16M 298
2020
Q4
$2.16M Buy
+9,412
New +$2.17M 0.54% 47
2019
Q4
Sell
-234
Closed -$45K 108
2019
Q3
$45K Buy
+234
New +$44.9K 0.03% 163

Other funds holding AMGN

Strategic Blueprint's AMGN Position: Q2 2026 in Review

Strategic Blueprint increased its Amgen (AMGN) stake by 16% in Q2 2026, buying an estimated $69.1K and bringing the position to 1,477 shares worth $535K. The position accounts for 0.03% of the portfolio, ranked #445.

Strategic Blueprint first reported a position in AMGN in Q3 2019 and has held it in 20 quarters since. The position peaked at $2.45M in Q3 2025. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Strategic Blueprint held 1,477 shares of Amgen worth $535K as of Q2 2026.
  • Strategic Blueprint bought 202 Amgen shares in Q2 2026, an estimated $69.1K.
  • Amgen made up 0.03% of Strategic Blueprint's portfolio in Q2 2026, its #445 holding.
  • Strategic Blueprint first reported a position in Amgen in Q3 2019 and has held it in 20 quarters since.
  • Strategic Blueprint's Amgen position peaked at $2.45M in Q3 2025.
  • 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Strategic Blueprint's 13F filing for Q2 2026, filed 23 Jul 2026.